Funding Opportunities

• Mobile Monitoring of Cognitive Change (U2C)
  (RFA-AG-18-012)
  National Institute on Aging
  Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MRSRCs) (P50)
  (RFA-AR-18-001)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): October 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: Research Resource for Systematic Reviews of Complementary and Integrative Health (R24)
  (RFA-AT-17-003)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): August 21, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Expanding Genome Integrity Assays to Population Studies (U01)
  (RFA-ES-17-006)
  National Institute of Environmental Health Sciences
  National Cancer Institute
  Application Receipt Date(s): October 13, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Academic Development of a Training Program for Good Laboratory Practices in High Containment Environments (U24)
  (RFA-FD-17-013)
  Food and Drug Administration
  Application Receipt Date(s): The application due date is August 29, 2017, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Global Pediatric Clinical Trials Network (U18)
  (RFA-FD-17-014)
  Food and Drug Administration
  Application Receipt Date(s): August 22, 2017, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Centers of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEER) (RM1)
  (RFA-HG-17-006)
  National Human Genome Research Institute
  Application Receipt Date(s): October 31, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24)
  (RFA-NS-17-024)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.